WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 9'7301 Infant (under 12 months) mortality rate: 252
GDP / capita (US$): 13'8921 Child (under 5 years) mortality rate: 282

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 16'271  16'098  15'921  15'744  15'568  14'576  16'172  14'519 
Births 340  342  343  340  333  234  375  356 
Surviving infants 332  334  334  331  324  225  355  333 
Pop. less than 5 years 1'665  1'641  1'571  1'518  1'454  1'091  1'837  1'674 
Pop. less than 15 years 4'154  4'066  3'966  3'890  3'822  4'036  5'097  4'715 
Female 15-49 years 4'437  4'435  4'437  4'418  4'398  4'040  4'052  3'716 

Number of reported case

(Click for retrospective incidence data for Kazakhstan)
Diphtheria 13  28 
Japanese encephalitis
Measles 55  127  20  245  273 
Mumps 67  51  82  131  240  3'236 
Pertussis 43  66  35  39  45  87  395 
Polio*
Rubella 13  44  622  3'350  14'989 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kazakhstan)
Vaccine year result method % card seen                                                
BCG 2009  100  MICS   65.9  95  96  96  96  97  98 
DTP1 2009  99  MICS   65.9  99  99  99  99  100  97 
DTP3 2009  97  MICS   65.9  100  99  99  98  99  97 
HepB_BD          96  96  96  97  95  98 
HepB3 2009  70  MICS   65.9  95  99  99  99  99  100 
Hib3          97  95  96  97  49 
JapEnc         
MCV 2009  94  MICS   65.9  96  100  99  99  100  99 
MCV2          97  99  100  99  99  99* 
PCV1          51 
PCV3          39 
Pol3 2009  88  MICS   65.9  99  99  98  99  99  97 
Rota1         
Rota_last         
Rubella1          100  99  99  100 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kazakhstan)
BCG 95  96  96  96  97  98 
DTP1 99  99  99  98  99  98 
DTP3 99  99  99  98  99  97 
HepB3 95  99  99  99  99  99 
Hib3 97  95  96  97  49 
MCV 96  99  99  99  99  99 
PCV3 37 
Pol3 98  99  98  99  99  96 
Rota_last

Number of districts in the country 204  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; 6 years; Yes
DT 6 years; Yes
DTwPHib 3, 18 months; Yes
DTwPHibHepB 2, 4 months;
Dip 12 years; Yes
HepA 2 years; Yes
HepB birth; 15 years; Yes
Influenza 6 months; 15 years; No
MMR 1, 6 year; Yes
MenACWY 15 years;
OPV 2, 3, 4, 12 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Td 16 years; Yes every 10 years
Typhoid 15 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes    No  No  No  No  No 
What years does the MYP cover? number 2012-2015            NA 
Nº of districts with microplans that include activities to raise immunization coverage number   205  204  204  204    201 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  No  No         

System performance

Total number of districts in country number 204  205  204  204  204  203  201 
Nº districts with DTP3 coverage >=80% number   205  204  204  204  203  201 
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   205  204  204  203     
% of districts with MCV1 coverage >=95% From 0 to 100%   100  100  100  100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%             100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.